Caitong International Asset Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$699K Buy
9,888
+9,862
+37,931% +$533K 0.1% 178
2026
Q1
$1.36K Buy
+26
New +$1.56K ﹤0.01% 1340
2025
Q4
Sell
-1,722
Closed -$95.8K 2361
2025
Q3
$95.8K Buy
1,722
+1,610
+1,438% +$86.2K 0.07% 178
2025
Q2
$5.76K Sell
112
-812
-88% -$40.8K ﹤0.01% 958
2025
Q1
$54.2K Buy
924
+855
+1,239% +$57.9K 0.04% 468
2024
Q4
$4.97K Buy
+69
New +$5.07K ﹤0.01% 1046

Other funds holding TECH

Caitong International Asset Management's TECH Position: Q2 2026 in Review

Caitong International Asset Management increased its Bio-Techne (TECH) stake by 37,931% in Q2 2026, buying an estimated $533K and bringing the position to 9,888 shares worth $699K. The position accounts for 0.1% of the portfolio, ranked #178.

Caitong International Asset Management first reported a position in TECH in Q4 2024 and has held it in 6 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Caitong International Asset Management held 9,888 shares of Bio-Techne worth $699K as of Q2 2026.
  • Caitong International Asset Management bought 9,862 Bio-Techne shares in Q2 2026, an estimated $533K.
  • Bio-Techne made up 0.1% of Caitong International Asset Management's portfolio in Q2 2026, its #178 holding.
  • Caitong International Asset Management first reported a position in Bio-Techne in Q4 2024 and has held it in 6 quarters since.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.